As of June 14, 2025, CNBX Pharmaceuticals Inc (CNBX) reports a Gross Margin of 100.00%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing CNBX Pharmaceuticals Inc's Gross Margin to Peers
To better understand CNBX Pharmaceuticals Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| CNBX Pharmaceuticals Inc (CNBX) | 100.00% |
| Protect Pharmaceutical Corporation Inc (PRTT) | 7775.20% |
| Pulmatrix Inc (PULM) | 7775.20% |
| Hoth Therapeutics Inc (HOTH) | 7775.20% |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 7775.20% |
| BetterLife Pharma Inc (BETR.CN) | 7775.20% |
Compared to its competitors, CNBX Pharmaceuticals Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.